Search

everythinglearnresearchcommunity

for

Search:↓

Identified genes linked to male-pattern baldness may help develop new treatments.

Certain peptides, caffeine, taurine, and an iron complex may improve hair regrowth when used with minoxidil and finasteride for hair loss.

Androgenetic alopecia is more common in Saudi men than women.

Hair transplants help transgender patients look more like their gender identity, with different procedures for trans women and men.

There's a significant link between severe hair loss and metabolic syndrome in Saudi Arabia, suggesting early health checks could prevent future issues.

Baldness is linked to a higher risk of coronary artery disease, but not to its severity.

Men with benign prostate hyperplasia have more meibomian gland loss and tear film problems.

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Topical 5% minoxidil is safe and effective for treating hair loss in Korean men.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

More people are using online platforms for hair loss treatment due to convenience and privacy.

PRP treatment mildly to moderately improves hair loss in most men with AGA.

Autologous Cellular Micrografts effectively treat hair loss with significant improvements and no dangerous side effects.

Higher platelet counts and activators in PRP improve hair density and thickness in treating hair loss.

ALRV5XR is the most effective hair regrowth treatment at 24 weeks.

Microneedling with PRP is as effective and safe as minoxidil+finasteride for treating hair loss.

Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.

Women know more about androgenetic alopecia than men.

Using lasers to deliver minoxidil can potentially improve its effectiveness in treating male pattern hair loss.

People with androgenetic alopecia have a higher risk of heart disease.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

Men with early-onset hair loss have more heart disease risk factors.

Early-onset hair loss in young males is linked to a higher risk of metabolic syndrome.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

Androgenetic alopecia is common in South-West Nigeria, affecting more men than women, with stress worsening the condition.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.